Previous Page  3 / 9 Next Page
Information
Show Menu
Previous Page 3 / 9 Next Page
Page Background

Volume 4, Issue 6(Suppl)

J Infect Dis Ther

ISSN: 2332-0877 JIDT, an open access journal

Influenza 2016

September 12-13, 2016

Page 21

Notes:

conference

series

.com

Influenza

September 12-13, 2016 Berlin, Germany

2

nd

International Conference on

Ian A Wilson, J Infect Dis Ther 2016, 4:6(Suppl)

http://dx.doi.org/10.4172/2332-0877.C1.013

Broad neutralization of influenza viruses and progress towards a universal vaccine and therapy

T

he major surface antigen, the hemagglutinin (HA) of influenza virus is the main target of neutralizing antibodies. However,

until recently, most antibodies were thought to be strain-specific and protect only against highly related strains within

the same subtype. However, in the past few years, many human antibodies have been isolated that are much broader and

neutralize across subtypes and groups of influenza A and B viruses through binding to functionally conserved sites. We have

determined structures of many broadly neutralizing antibodies with HAs and determined that their epitopes map to highly

conserved sites on the HA fusion domains (stem) and receptor binding sites (head). The identification and characterization of

the epitopes and mode of binding of these antibodies have elucidated recognition motifs and conserved sites of vulnerability

that provide exciting new opportunities for structure-assisted vaccine design as well as for design of therapeutics that afford

greater protection against influenza viruses.

Biography

Ian A Wilson has received his BSc in Biochemistry from Edinburgh University, DPhil in Molecular Biophysics from Oxford University and did Postdoctoral research

at Harvard University. He has been a Professor at The Scripps Research Institute since 1982 and is Hansen Professor of Structural Biology and Chair of the

Department Integrative Structural and Computational Biology. His laboratory focuses on recognition of microbial pathogens by the immune system and structure-

based design of vaccines and therapeutics. He is a Fellow of the Royal Society, Fellow of the Royal Society of Edinburgh, Member of the American Academy of

Arts and Sciences and has a DSc degree from Oxford University and published over 665 papers.

wilson@scripps.edu

Ian AWilson

The Scripps Research Institute, USA